Lamivudine and famciclovir combination therapy with or without addition of IFN-alfa-2b for HBeAg positive chronic hepatitis B

被引：0
|
作者：
Sangfelt, BP
Uhnoo, I
Hollander, A
Lindh, G
Weiland, O
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Univ Uppsala Hosp, Uppsala, Sweden
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1867
引用
收藏
页码：630A / 630A
页数：1
相关论文
共 50 条
  • [11] A randomized trial of peginteferon alfa-2b and lamivudine combination treatment versus lamivudine monotherapy in Chinese patients with HBeAg-positive chronic hepatitis B
    Chan, HLY
    Leung, NWY
    Hui, AY
    Liew, CT
    Chim, AML
    Chan, FKL
    Hung, LCT
    Sung, JJY
    JOURNAL OF HEPATOLOGY, 2004, 40 : 125 - 126
  • [12] Randomized trial of lamivudine, adefovir, and the combination in HBeAg-positive chronic hepatitis B
    He, Zebao
    Wang, Jiefei
    Liu, Kezhou
    Huang, Haibin
    Du, Yao
    Lin, Zongmei
    Cai, Miaoguo
    Feng, Xinghua
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (06) : 592 - 597
  • [13] Relapse after treatment with peginterferon a-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B
    Flink, H. J.
    Buster, E. H. C. J.
    Merican, I.
    Nevens, F.
    Kitis, G.
    Cianciara, J.
    De Vries, R. A.
    Hansen, B. E.
    Schalm, S. W.
    Janssen, H. L. A.
    GUT, 2007, 56 (10) : 1485 - 1486
  • [14] Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B
    Yurdaydin, C
    Bozkaya, H
    Çetinkaya, H
    Sahin, T
    Karaoguz, D
    Törüner, M
    Erkan, Ö
    Heper, AO
    Erden, E
    Bozdayi, AM
    Uzunalimoglu, Ö
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (03) : 262 - 268
  • [15] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Peng, Cheng-Yuan
    Shih, Chao-Jen
    Lo, Pei-Shuan
    Huang, Chia-Lin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Kao, Jung-Ta
    HEPATOLOGY, 2011, 54 : 1027A - 1028A
  • [16] The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.
    Canbakan, B
    Senturk, H
    Tabak, F
    Akdogan, M
    Ozaras, R
    Tahan, V
    Mert, A
    Ozbay, G
    GASTROENTEROLOGY, 2005, 128 (04) : A771 - A772
  • [17] Comparison of lamivudine monotherapy with lamivudine plus interferon alpha combination in patients with HBeAg positive chronic hepatitis B
    Karasu, Z
    Ersoz, C
    Akarca, U
    Gunsar, F
    Vardar, R
    Batur, Y
    JOURNAL OF HEPATOLOGY, 2001, 34 : 177 - 178
  • [18] Lamivudine therapy in HBeAg negative chronic hepatitis B patients
    Guclu, E.
    Batirel, A.
    Ince, N. Koc
    Ogutlu, A.
    Durmaz, Y.
    Ozdemir, D.
    Geyik, M. F.
    Karabay, O.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 444 - 444
  • [19] HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
    Fried, Michael W.
    Piratvisuth, Teerha
    Lau, George K. K.
    Marcellin, Patrick
    Chow, Wan-Cheng
    Cooksley, Graham
    Luo, Kang-Xian
    Paik, Seung Woon
    Liaw, Yun-Fan
    Button, Peter
    Popescu, Matei
    HEPATOLOGY, 2008, 47 (02) : 428 - 434
  • [20] Higher efficacy of sequential therapy with interferon-α and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients
    Sarin, SK
    Kumar, M
    Kumar, R
    Kazim, SN
    Guptan, RC
    Sakhuja, P
    Sharma, BC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2463 - 2471
12345